XML 110 R57.htm IDEA: XBRL DOCUMENT v3.25.4
BENEFIT PLANS (Tables)
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Schedule of restricted stock issuances The following table summarizes the restricted stock issuances under the Company’s 2015 and 2023 Stock Incentive Plans, net of shares forfeited, if any:
2023 Plan1
2015 Plan
Restricted Stock authorized under the plan2
3.0 million1.5 million
Net restricted stock (granted)/forfeited during:
Year ended December 31, 2021 and prior(438)
Year ended December 31, 2022(251)
Year ended December 31, 2023(82)28
Year ended December 31, 2024(497)
Year ended December 31, 20251825
Total net restricted stock (granted)/forfeited(561)(636)
1    The Company’s 2023 Stock Incentive Plan provides for an initial share reserve of up to 3.0 million shares of Common Stock.
2    No stock options were granted under the Company’s 2015 or 2023 Stock Incentive Plans.
The following table summarizes the Company’s ESPP activity from inception through December 31, 2025:

Year Ended December 31,
202520242023
Offering Period Dates
Shares purchased
Weighted avg share price
Total purchased, net of discountShares purchased
Weighted avg share price
Total purchased, net of discountShares purchased
Weighted avg share price
Total purchased, net of discount
CommencementEnd
10/1/20233/15/2024— $— — $9.83 51 $13.05 51 
4/1/20249/15/2024— $— — 10 $10.21 101 — $— — 
10/1/20243/15/2025$10.97 $48 $11.03 55 — $— — 
4/1/20259/15/202514 $9.95 $142 — $— — — $— — 
10/1/202512/15/2025$10.23 $77 — $— — — $— — 
Totals26 $10.19 $267 20 $10.32 $207 $10.32 $51 

The ESPP share activity is as follows:
Shares
ESPP shares authorized under the plan200 
ESPP shares purchased during:
Year ended December 31, 2023 (4)
Year ended December 31, 2024(20)
Year ended December 31, 2025(26)
Available for future purchases, December 31, 2025150 
Investment company, changes in net assets
Details of the Company’s outstanding shares related to restricted stock awards as of December 31, 2025 and December 31, 2024 are outlined below:

December 31, 2025December 31, 2024
Shares outstanding related to grants of restricted stock awards245771
Weighted average grant date fair value of awards$13.41$14.51
Additional shares outstanding related to dividends on awards3159
Schedule of unrecognized compensation
As of December 31, 2025 and December 31, 2024, the Company’s total unrecognized compensation expense related to unvested shares of restricted stock granted was as follows:

December 31, 2025December 31, 2024
Unrecognized compensation expense on unvested awards$2,680$5,929
Weighted-average period of unrecognized compensation expense1.3 years1.0 year
The Company’s total stock-based compensation expense included within Salaries and employee benefits expense in the Consolidated Statements of Income for the years ended December 31, 2025, 2024 and 2023 is summarized below:

Year Ended December 31,
202520242023
Restricted stock awards$4,052 $4,040 $2,828 
ESPP45 22 — 
Total compensation cost recognized for stock-based compensation plans$4,097 $4,062 $2,828